130 related articles for article (PubMed ID: 6133269)
21. Ranitidine--pharmacology and clinical use.
Dawson J; Richards DA; Stables R; Dixon GT; Cockel R
J Clin Hosp Pharm; 1983 Mar; 8(1):1-13. PubMed ID: 6132928
[No Abstract] [Full Text] [Related]
22. Use and abuse of H2 receptor antagonists.
Hunt RH
J R Coll Physicians Lond; 1982 Jan; 16(1):33-9. PubMed ID: 6121053
[No Abstract] [Full Text] [Related]
23. [Acid anti-secretion therapy in gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
[No Abstract] [Full Text] [Related]
24. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
Noya G; Dettori G; Antona C; Niolu P; Muscas A; Marongiu G; Biglioli P
Minerva Med; 1983 Mar; 74(13):691-3. PubMed ID: 6132353
[TBL] [Abstract][Full Text] [Related]
25. Ranitidine in the treatment of acute upper gastrointestinal haemorrhage--a comparative study. Preliminary report.
Nowak A; Sadliński C; Górka Z; Nowakowska E; Rudzki J; Gibiński K
Hepatogastroenterology; 1981 Oct; 28(5):267-9. PubMed ID: 6124495
[TBL] [Abstract][Full Text] [Related]
26. Another look at peptic ulcer.
Piper DW; Barr GD
Aust Fam Physician; 1981 Aug; 10(8):636-40. PubMed ID: 6117272
[No Abstract] [Full Text] [Related]
27. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
Helman CA; Tim LO
Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
[TBL] [Abstract][Full Text] [Related]
29. [Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results].
Simon B; Dammann HG; Müller P; Kather H
Dtsch Med Wochenschr; 1980 Dec; 105(50):1753-5. PubMed ID: 6108203
[No Abstract] [Full Text] [Related]
30. [Therapeutic achlorhydria: for which diseases, when and for how long?].
Koop H; Arnold R
Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969
[No Abstract] [Full Text] [Related]
31. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
32. [Ranitidine: an alternative to cimetidine in the treatment of duodenal ulcer].
Simon B; Müller P; Dammann HG; Kather H
MMW Munch Med Wochenschr; 1981 Jun; 123(25):1049-50. PubMed ID: 6114426
[No Abstract] [Full Text] [Related]
33. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
Korman MG; Hansky J; Eaves ER; Schmidt GT
Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
[TBL] [Abstract][Full Text] [Related]
34. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Yeomans ND; Tulassay Z; Juhász L; Rácz I; Howard JM; van Rensburg CJ; Swannell AJ; Hawkey CJ
N Engl J Med; 1998 Mar; 338(11):719-26. PubMed ID: 9494148
[TBL] [Abstract][Full Text] [Related]
35. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
36. Ranitidine and cimetidine for duodenal ulcer.
Langman MJ; Henry DA; Ogilvie A
Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
[No Abstract] [Full Text] [Related]
37. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of duodenal ulcer with famotidine].
Schütze K; Hentschel E; Reichel W; Kerstan E
Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
[TBL] [Abstract][Full Text] [Related]
39. New histamine H2-receptor antagonists.
Domschke S; Domschke W
Hepatogastroenterology; 1980 Jun; 27(3):163-8. PubMed ID: 6109690
[No Abstract] [Full Text] [Related]
40. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
Simon B; Müller P; Dammann HG
Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
